Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2026-02-25 @ 4:58 PM
Study NCT ID:
NCT00660803
Status:
COMPLETED
Last Update Posted:
2010-01-21
First Post:
2008-04-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer
Status:
COMPLETED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Characterize the demographic and clinical features, as well as the main treatment results, among patients with advanced breast cancer treated with fulvestrant in Brazil.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: